The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 136,564 | 119,802 | 104,406 | 100,267 | 99,901 |
| Cost of Goods | 117,644 | 102,301 | 87,157 | 85,631 | 85,535 |
| Gross Profit | 18,920 | 17,501 | 17,249 | 14,636 | 14,366 |
| Operating Expenses | 27,618 | 29,013 | 27,317 | 27,196 | 28,754 |
| Operating Income | -8,054 | -11,211 | -9,911 | -11,929 | -13,853 |
| Interest Expense | 1,920 | 1,870 | 5,570 | 1,168 | 2,225 |
| Other Income | -6,530 | -4,059 | -4,104 | -85 | -35 |
| Pre-tax Income | -16,504 | -17,140 | -19,585 | -13,182 | -16,113 |
| Income Tax | N/A | -131 | N/A | N/A | N/A |
| Net Income Continuous | -16,504 | -17,009 | -19,585 | -13,182 | -16,113 |
| Net Income | $-16,504 | $-17,009 | $-19,585 | $-13,182 | $-16,113 |
| EPS Basic Total Ops | -0.14 | -0.15 | -0.21 | -0.14 | -0.18 |
| EPS Basic Continuous Ops | -0.17 | -0.18 | -0.25 | -0.17 | -0.21 |
| EPS Diluted Total Ops | -0.14 | -0.15 | -0.21 | -0.14 | -0.18 |
| EPS Diluted Continuous Ops | -0.17 | -0.18 | -0.25 | -0.17 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.15 | -0.18 | -0.14 | -0.18 |
| EBITDA(a) | $-5,159 | $-8,277 | $-3,253 | $-8,629 | $-10,741 |